Healthcare Disrupted: A Post-Election View
Join us for the November Alumni Breakfast Series in New York as Jeff Elton discusses his book, Healthcare Disrupted. Healthcare Disrupted is a global view of one of the largest industry sectors in the world, that impacts each of us personally. Originally published in English and now coming out in a Chinese language edition covering the rapidly growing Asian market for healthcare and life science products, this original research highlights the fundamental and irreversible changes in health care funding – from volume and inputs, to value and outcomes – and the implications of advanced analytics; vast amounts of digital medical and health data; and the emergence of high efficacy digital health and medical technologies. The authors define the novel business models of emerging and future leaders, the rising role of a 'health consumer,' and disruptive influence of digital health and digital medical services firms on current healthcare provider, payer and life science company incumbents.
Priority will be given to Chicago Booth alumni.
Jeff Elton, AB '81, MBA '84, PhD '91 (Speaker)
Managing Director - Strategy, Life Sciences & Head Predictive Health Intelligence, Accenture
Jeff Elton, Ph.D. is Managing Director - Strategy, Life Sciences & Head Predictive Health Intelligence, focused advanced real-world analytics and the next generation of value and outcomes-centric business models for healthcare organizations and life science companies. He is the co-author of the recently published and well received book, Healthcare Disrupted (Wiley, 2016).
Jeff has over 25 years of experience as a global executive and consultant in the healthcare and life sciences. Jeff previously was Senior Vice President of Strategy and Global Chief Operating Officer at Novartis Institutes of BioMedical Research, Inc.; founding CEO of an oncology molecular diagnostics and therapeutic pathways company; and founding board member and senior advisor to several early stage companies in Parkinson's Disease treatment, protein therapeutics, diabetes, oncology therapeutics, and oncology diagnostics.
Jeff is currently a board member of the Massachusetts Biotechnology Council. Jeff is former partner with McKinsey & Company and adjunct faculty at Boston University, Questrom School of Business, in Health Sector Management. Jeff has a Ph.D. and M.B.A. from The University of Chicago, Booth School of Business.
Office of Advancement